Human recombinant interleukin-1 receptor antagonist in the treatment of sepsis syndrome
- PMID: 8124969
- DOI: 10.1097/00003246-199401000-00002
Human recombinant interleukin-1 receptor antagonist in the treatment of sepsis syndrome
Comment on
-
Initial evaluation of human recombinant interleukin-1 receptor antagonist in the treatment of sepsis syndrome: a randomized, open-label, placebo-controlled multicenter trial.Crit Care Med. 1994 Jan;22(1):12-21. doi: 10.1097/00003246-199401000-00008. Crit Care Med. 1994. PMID: 8124953 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources